Last reviewed · How we verify

NCT03726528: OCTOPUS

Optimized Characterization of Takotsubo Syndrome by Obtaining Pressure Volume Loops

Completed NA Last updated 19 October 2022
What this trial tests

NA trial testing Measurements of left ventricular pressure and volume in Takotsubo Syndrome in 25 participants. Completed in 7 October 2022.

Timeline
1 September 2017
Primary endpoint
7 October 2022
7 October 2022

Quick facts

Lead sponsorUniversity of Luebeck
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment25
Start date1 September 2017
Primary completion7 October 2022
Estimated completion7 October 2022
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Luebeck

Who can join

18 and older, any sex, with Takotsubo Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of this prospective study is to assess the pathophysiology of Takotsubo Syndrome by obtaining pressure volume loops with conductance catheters, which allows detailed conclusions regarding systolic and diastolic hemondynamics and subsequently regarding potential underlying mechanisms

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Hemodynamic Assessment in Takotsubo Syndrome.
    Stiermaier T, Reil JC, Sequeira V, Rawish E, et al · · 2023 · cited 17× · PMID 37197841 · DOI 10.1016/j.jacc.2023.03.398
  2. Regional mechanical dyssynchrony and shortened systole are present in people with Takotsubo syndrome.
    Reil JC, Sequeira V, Reil GH, Steendijk P, et al · · 2024 · PMID 39487225 · DOI 10.1038/s43856-024-00641-5

Verify or expand the search:

Other recruiting trials for Takotsubo Syndrome

Currently open trials in the same condition.

Other University of Luebeck trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03726528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing